了解卢旺达的疟疾治疗坚持:对素耐药性的影响
Pierre Gashema1,2, Aileen Jordan1, Eric Saramba3
1College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
The American journal of tropical medicine and hygiene
|October 28, 2025
概括
尽管卢旺达的疟疾知识很高,但治疗坚持不佳,许多患者没有完成药物治疗课程. 这种较低的坚持风险加剧了社区中抗疟疾药物耐药性的风险.
科学领域:
- 全球健康 全球健康
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 及时诊断疟疾和有效治疗是关键干预措施.
- 卢旺达新出现的抗素耐药性需要最佳的社区治疗实践.
- 社区的知识和坚持对疟疾治疗结果产生重大影响.
研究的目的:
- 检查卢旺达政府诊所中发烧患者的疟疾知识,态度和实践.
- 确定影响疟疾治疗实践和遵守的因素.
- 为改善卢旺达抗疟疾药物遵守的干预措施提供信息.
主要方法:
- 在卢旺达中等到高疟疾传播地区的六个卫生机构进行了一项横截面研究.
- 采用半结构化问卷,采访了406名患者或患有发烧儿童的照顾者.
- 数据收集发生在2023年12月至2024年2月.
主要成果:
- 观察到高度的疟疾知识:81%的人知道症状,72%的人了解传播,74.6%的人知道控制措施.
- 尽管知识丰富,但仅有46%的接受疟疾治疗的患者完成了整个3天的疗程.
- 观察到不良坚持,有37%的人在2天内停止服用药物,11%的人超过3天.
结论:
- 卢旺达的高疟疾知识与发烧患者治疗坚持不良的情况形成鲜明对比.
- 低于最佳的抗疟疾药物的坚持对抗药物耐药性的发展和传播构成重大风险.
- 需要紧急干预,以改善抗疟疾药物的坚持,特别是在有记录耐药性的地区.
相关概念视频
01:28Pulmonary Tuberculosis V
532
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
532
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K